Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation

Intravesical bacillus Calmette-Guerin (BCG) therapy is the gold standard treatment option in high-risk non-invasive bladder cancer. However, BCG is a very toxic agent. A significant proportion of patients have BCG intolerance after beginning intravesical treatment. Radical cystectomy is the recommen...

Full description

Saved in:
Bibliographic Details
Published in:Üroonkoloji bülteni 2018-06, Vol.17 (2), p.63-67
Main Authors: Girgin, Reha, Mungan, N. Aydın
Format: Article
Language:English
Subjects:
Acids
Bladder cancer
Cancer therapies
Cell cycle
Cell division
Chemotherapy
Endoscopy
Immunotherapy
Metastasis
Permeability
Photodynamic therapy
Response rates
Tıp
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Intravesical bacillus Calmette-Guerin (BCG) therapy is the gold standard treatment option in high-risk non-invasive bladder cancer. However, BCG is a very toxic agent. A significant proportion of patients have BCG intolerance after beginning intravesical treatment. Radical cystectomy is the recommended approach for patients with either BCG failure or BCG intolerance. Alternative intravesical salvage treatments are needed for patients who cannot tolerate radical cystectomy due to comorbidities or who refuse surgery. In this review, current intravesical treatment alternatives to radical cystectomy in intravesical BCG failure are discussed with oncologic outcomes.
ISSN:2147-2270
2147-2122
2147-2270
DOI:10.4274/uob.967